Hypoxia Dose Painting by Numbers: A Planning Study

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 1, 2007, Pages 291-300

  Thorwarth, Daniela ^a   Eschmann, Susanne Martina ^a   Paulsen, Frank ^a   Alber, Markus ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

18F fluoromisonidazole; Dose painting; Dose painting by numbers; Hypoxia; IMRT; Planning study

Indexed keywords

GLUCOSE; MEDICAL IMAGING; MEDICAL PROBLEMS; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TOXICITY; TUMORS;

DOSE PAINTING; FLUOROMISONIDAZOLE; HYPOXIA; IMRT; PLANNING STUDY; RADIATION INSENSITIVITY;

DOSIMETRY;

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; FLUORODEOXYGLUCOSE;

ARTICLE; CALCULATION; CANCER CONTROL; CANCER RADIOTHERAPY; DIAGNOSTIC IMAGING; DOSE RESPONSE; HEAD AND NECK CANCER; HUMAN; HYPOXIA; INTENSITY MODULATED RADIATION THERAPY; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; TREATMENT PLANNING; TUMOR VOLUME;

CELL HYPOXIA; FEASIBILITY STUDIES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MISONIDAZOLE; RADIATION-SENSITIZING AGENTS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 34247139696     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.11.061     Document Type: Article

References (31)

1. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
2. Hicks R.J., Kalff V., MacManus M.P., et al. 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 42 (2001) 1596-1604
3. 18F]FDG-PET imaging in small cell lung cancer. Eur J Nucl Med Mol Imaging 30 (2003) 78-84
4. Shields A.F., Grierson J.R., Dohmen B.M., et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nature Med 4 (1998) 1334-1336
5. Eschmann S.M., Paulsen F., Reimold M., et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46 (2005) 253-260
6. Hicks R.J., Rischin D., Fisher R., et al. Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent. Eur J Nucl Med Mol Imaging 32 (2005) 1384-1391
7. Rasey J.S., Koh W.J., Evans M.L., et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 36 (1996) 417-428
8. 18F-fluoroazomycin arabinoside. J Nucl Med 46 (2005) 106-113
9. 60Cu-ATSM: Relationship to therapeutic response-A preliminary report. Int J Radiat Oncol Biol Phys 55 (2003) 1233-1238
10. Grosu A.-L., Piert M., and Molls M. Experience of PET for target localisation in radiation oncology. Br J Radiol Suppl. 28 (2005) 18-32
11. Rajendran J.G., Hendrickson K.R., Spence A.M., et al. Hypoxia imaging-directed radiation treatment planning. Eur J Nucl Med Mol Imaging 33 Suppl. 13 (2006) 44-53
12. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
13. Alber M., Paulsen F., Eschmann S.M., et al. On biologically conformal boost dose optimization. Phys Med Biol 48 (2003) N31-N35
14. Bentzen S.M. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
15. Brizel D.M., Sibley G.S., Prosnitz L.R., et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38 (1997) 285-289
16. Nordsmark M., and Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 57 (2000) 39-43
17. Nordsmark M., Overgaard M., and Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41 (1996) 31-39
18. Fyles A., Milosevic M., Hedley D., et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20 (2002) 680-687
19. Kaanders J.H.A.M., Bussink J., and van der Kogel A. ARCON: A novel biology-based approach in radiotherapy. Lancet Oncol 3 (2002) 728-737
20. Vanderstraeten B., Duthoy W., De Gersem W., et al. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol 79 (2006) 249-258
21. Das S.K., Miften M.M., Zhou S., et al. Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions. Med Phys 31 (2004) 1452-1461
22. Thorwarth D., Eschmann S.M., Scheiderbauer J., et al. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer 5 (2005) 152
23. 18F]-Fmiso PET data to analyse tumor hypoxia. Phys Med Biol 50 (2005) 2209-2224
24. Carlson D.J., Stewart R.D., and Semenenko V.A. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. Med Phys 33 (2006) 3105-3115
25. Popple R.A., Ove R., and Shen S. Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. Int J Radiat Oncol Biol Phys 54 (2002) 921-927
26. Tome W.A., and Fowler J.F. Selective boosting of tumor subvolumes. Int J Radiat Oncol Biol Phys 48 (2000) 593-599
27. Jelen U., Söhn M., and Alber M. A finite size pencil beam for IMRT dose optimization. Phys Med Biol 50 (2005) 1747-1766
28. Pekkola-Heino K., Jaakkola M., Kulmala J., et al. Comparison of cellular radiosensitivity between different localizations of head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 121 (1995) 452-456
29. Apisarnthanarax S., and Chao K.S.C. Current imaging paradigms in radiation oncology. Radiat Res 163 (2005) 1-25
30. Dewhirst M.W., Kimura H., Rehmus S.W., et al. Microvascular studies on the origins of perfusion-limited hypoxia. Br J Cancer Suppl 27 (1996) S247-S251
31. Troost E.G., Laverman P., Kaanders J.H., et al. Imaging hypoxia after oxygenation-modification: Comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors. Radiother Oncol 80 (2006) 157-164